These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12149209)

  • 1. Role of p38 and ERK MAP kinase in proliferation of erythroid progenitors in response to stimulation by soluble and membrane isoforms of stem cell factor.
    Kapur R; Chandra S; Cooper R; McCarthy J; Williams DA
    Blood; 2002 Aug; 100(4):1287-93. PubMed ID: 12149209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through the interaction of membrane-restricted stem cell factor and c-kit receptor tyrosine kinase: genetic evidence for a differential role in erythropoiesis.
    Kapur R; Majumdar M; Xiao X; McAndrews-Hill M; Schindler K; Williams DA
    Blood; 1998 Feb; 91(3):879-89. PubMed ID: 9446648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of novel amino acids in the cytoplasmic domain of stem cell factor results in hematopoietic defects in Steel(17H) mice.
    Kapur R; Cooper R; Xiao X; Weiss MJ; Donovan P; Williams DA
    Blood; 1999 Sep; 94(6):1915-25. PubMed ID: 10477720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways.
    Kapur R; Cooper R; Zhang L; Williams DA
    Blood; 2001 Apr; 97(7):1975-81. PubMed ID: 11264161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
    Sui X; Krantz SB; Zhao ZJ
    Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
    Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
    Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
    Pearson MA; O'Farrell AM; Dexter TM; Whetton AD; Owen-Lynch PJ; Heyworth CM
    Growth Factors; 1998; 15(4):293-306. PubMed ID: 9714913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors.
    Somervaille TC; Linch DC; Khwaja A
    Br J Haematol; 2003 Mar; 120(5):876-86. PubMed ID: 12614225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration.
    Ueda S; Mizuki M; Ikeda H; Tsujimura T; Matsumura I; Nakano K; Daino H; Honda Zi Z; Sonoyama J; Shibayama H; Sugahara H; Machii T; Kanakura Y
    Blood; 2002 May; 99(9):3342-9. PubMed ID: 11964302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
    Zhang J; Lodish HF
    Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity.
    Sundström M; Alfredsson J; Olsson N; Nilsson G
    Exp Cell Res; 2001 Jul; 267(1):144-51. PubMed ID: 11412047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency.
    Nishio M; Oda A; Koizumi K; Satoh I; Sato Y; Endoh T; Tsutsumi A; Fujihara M; Ikebuchi K; Ikeda H; Koike T; Sawada KI
    Exp Hematol; 2001 Jan; 29(1):19-29. PubMed ID: 11164102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
    Kapur R; Zhang L
    J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
    Sawafuji K; Miyakawa Y; Kizaki M; Ikeda Y
    Am J Hematol; 2003 Jan; 72(1):67-9. PubMed ID: 12508271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
    Arcasoy MO; Jiang X
    Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of human stem cell factor impairs melanocyte, mast cell, and thymocyte development: a role for receptor tyrosine kinase-mediated mitogen activated protein kinase activation in cell differentiation.
    Kapur R; Everett ET; Uffman J; McAndrews-Hill M; Cooper R; Ryder J; Vik T; Williams DA
    Blood; 1997 Oct; 90(8):3018-26. PubMed ID: 9376582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins.
    Zeuner A; Pedini F; Signore M; Testa U; Pelosi E; Peschle C; De Maria R
    Blood; 2003 Jul; 102(1):87-93. PubMed ID: 12637332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.